Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Gross Margin (2018 - 2025)

TransMedics (TMDX) has 8 years of Gross Margin data on record, last reported at 58.11% in Q4 2025.

  • For Q4 2025, Gross Margin fell 110.0% year-over-year to 58.11%; the TTM value through Dec 2025 reached 59.92%, up 56.0%, while the annual FY2025 figure was 59.92%, 56.0% up from the prior year.
  • Gross Margin reached 58.11% in Q4 2025 per TMDX's latest filing, down from 58.8% in the prior quarter.
  • Across five years, Gross Margin topped out at 76.22% in Q1 2022 and bottomed at 55.94% in Q3 2024.
  • Average Gross Margin over 5 years is 64.45%, with a median of 62.45% recorded in 2024.
  • Peak YoY movement for Gross Margin: soared 1323bps in 2022, then plummeted -944bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 72.26% in 2021, then fell by -9bps to 65.99% in 2022, then fell by -11bps to 59.04% in 2023, then grew by 0bps to 59.21% in 2024, then decreased by -2bps to 58.11% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 58.11% in Q4 2025, 58.8% in Q3 2025, and 61.38% in Q2 2025.